PRETORIA (September 18, 2023)—Kyrgyzstan, Ukraine, and Uzbekistan – participants in the LIFT-TB project – have updated their National Tuberculosis (TB) Clinical Guidelines to endorse the all-oral, six-month BPaL/M (bedaquiline + pretomanid + linezolid ± moxifloxacin) regimen(s) as the national standard for treating most patients with drug-resistant tuberculosis (DR-TB).

In 2018, India articulated its noble ambition to eliminate TB by 2025, five years before the global target. But news reports show we aren’t even close to that goal.

In a recent study published in The Lancet Microbe, researchers evaluated the diagnostic accuracy of upper respiratory tract samples for active pulmonary tuberculosis (TB) compared to standard sputum or gastric aspirate testing.

U.S.-based pharmaceuticals company Johnson & Johnson is being investigated in South Africa for allegedly charging “excessive” prices for a key tuberculosis drug, the country's antitrust regulator said Friday (15 September).

The Stop TB Partnership announced several high-level events ahead of the United Nations High-Level Meeting on TB to be held on 22 September 2023 in New York City.

Without action, more than 27 million lives could be lost between now and 2050.

Ahead of the High-Level Meeting on TB, Médecins Sans Frontières conducted a webinar on 8 September 2023 to provide information about the next phase of the Time for $5 Campaign, calling on the diagnostics company Cepheid and its parent corporation Danaher to reduce the price of the GeneXpert test cartridge to $5.

TB is curable but remains the world’s leading infectious disease killer as pharma corporations stand in the way of affordable medical tools.

WHO urges world leaders to commit to progress on pandemic prevention, preparedness and response and to secure health for all, end TB, and reinvigorate SDGs.

The Accountability Report of TB Civil Society and Affected Communities: Priorities to Close the Deadly Divide now available online in English, Spanish, French, Portuguese and Russian.